Abstract
Our article “A systematic approach to billing laboratory services – the legal framework” [Rathenberg et al., J Lab Med 2014;38(4):179–205] reviewed all relevant aspects of billing laboratory services. Here we provide supplementary information due to further legal advancements based on the German health-care law, with emphasis on specialist outpatient care (Ambulante spezialfachärztliche Versorgung [ASV]) and selective contracts and complexes of services. In addition, we focus on occupational medicine as well as billing in connection with hospital emergency departments.
Reviewed Publication:
März W.
List of abbreviations: ASV, Outpatient specialist care; ASV-AV, agreement in accordance with Section 116b para 6 sentence 12 SGB (Social Code) V regarding the form and content of the billing procedure and the necessary forms for outpatient specialist care. EBM, uniform rating scale; GOÄ, fee schedule for doctors; HzV, medical care centered on family physicians; KV, Association of Statutory Health Insurance Physicians; MVZ, medical care center.
1 Outpatient specialist care (ASV) according to Section 116b SGB V
With respect to outpatient specialist care (ASV), our review article “Systematic approach to billing laboratory services – the legal framework”[1] has thus far been limited to the statement that Section 116b SGB V regulates ASV services “for example, at hospitals” and that the laboratory[2] to which services are outsourced must issue an invoice to the hospital.[3] The current 2-year periods in accordance with Section 116b para. 8 SGB V and the related decision-making processes at hospitals eligible under the former Section 116b SGB V regarding their future participation in ASV, however, require an update to this topic, particularly from the point of view of the laboratory. The changes to the legal framework that have brought about the current situation are summarized herein below, as are the consequences for the billing of lab services.
1.1 Changes in legal framework
The new version of Section 116b SGB V[4] created the services sector under ASV, where in addition to the hospitals that had already been eligible under the former Section 116b SGB V, service providers were now also eligible to participate in panel-doctor-based medical care, that is, panel doctors, medical care centers (MVZ), authorized physicians and facilities. ASV comprises, in accordance with Section 116b para. 1 SGB V, the diagnosis and treatment of complex, difficult-to-treat diseases that require special qualifications, interdisciplinary collaboration and special equipment depending on the disease. More detailed regulations on ASV can be found – as provided for in Section 116b paragraph 4 SGB V – in the directive of the Federal Joint Committee on outpatient specialist care according to Section 116b SGB V[5] (“ASV Directive”), whose schedules specify the diseases covered by ASV and define the scope of treatment. To date, four of these schedules have been adopted: on tuberculosis,[6] on gastrointestinal tumors,[7] on gynecological tumors[8] and on Marfan’s syndrome.[9] Other schedules – for example, concerning rheumatism and heart failure – will follow.
To date, numerous hospitals still have privileges for outpatient treatment according to Section 116b SGB V (old version) based on a state provision in accordance with Section 116b para. 2 SGB V (old version). The new Section 116b para. 8 SGB V provides that those provisions of the federal state will continue to be valid until their repeal by the state. This repeal must occur no later than 2 years after entry into force of the directive resolution of the Joint Federal Committee regarding the respective disease. For ASV in connection with tuberculosis, for example, the state provisions will therefore have to be repealed by 23.04.2016, but may be repealed sooner as well. For hospitals providing outpatient care under the former regulations, this now raises the question whether they will be able to participate in ASV and meet the legal requirements in the future.
1.2 Requirements for participation in ASV
The ASV-eligible parties defined in Section 2 para. 1 of the ASV Directive (service providers that are part of panel doctor care and hospitals licensed under Section 108 SGB V) can participate in ASV if and where they meet the personnel, material and organizational requirements for the individual diseases under the ASV Directive and the respective directive resolutions. The key requirements are presented below.
1.2.1 Interdisciplinary cooperation
ASV regularly requires cooperation within an interdisciplinary team (Section 3 para. 1 ASV Directive), which can be ensured in different ways:
If a service provider can meet the requirement of interdisciplinary cooperation itself, that is, in-house, it will not have to enter into a cooperation with an external service provider – except for cases involving care for patients with severe progressions of oncological conditions.[10] This is true, for example, of hospitals that offer all necessary disciplines.
If a service provider cannot ensure interdisciplinary cooperation in-house, it may join forces with various service providers (which must be ASV-eligible) to meet jointly the requirements for individual diseases under the directive resolutions of the Federal Joint Committee. This type of service cooperation is not mandatory, but can help obtain an ASV authorization if the interdisciplinary cooperation requirement is met in this way (cf. Section 1 para. 1 sentence 2 ASV Directive). This service cooperation can span sectors (between the hospital and panel doctors) or take place within a care sector (e.g. between two hospitals or between two panel-doctor facilities).
In deviation thereof, ASV cooperation requires an intersectoral association for the care of patients with severe progressions of oncological conditions (Section 116b para. 4 sentence 10 SGB V, Section 10 para. 1 sentence 2 ASV Directive). An exception from this cooperation requirement can be granted under Section 116b para. 4 sentence 11 SGB V only if an ASV-relevant catchment area does not have a suitable cooperation partner or if a service provider, despite serious efforts, fails to find a willing and/or suitable cooperation partner within a period of at least 2 months.
In summary, therefore, this means that the care for patients with severe progressions of oncological conditions always requires intersectoral ASV cooperation, and that in all circumstances regulated thus far the service provider may ensure interdisciplinary cooperation in-house or join forces with one or several external cooperation partners to meet this requirement. For reasons of legal certainty, all these arrangements should be supported by written cooperation agreements.
1.2.2 Composition of the interdisciplinary team
The interdisciplinary team responsible for interdisciplinary cooperation consists of a team leader, a core team and specialist doctors that can be called upon in real time in case of medical emergency (Section 3 para. 2 sentence 1 ASV Directive). The qualification requirements for all team members as well as the material and organizational requirements are subject to the respective schedules of the ASV Directive. Table 1 shows the functions that the laboratory can perform in the context of the interdisciplinary team with respect to the schedules of the ASV Directive adopted to date. Furthermore, the team members must have a billing authorization in at least one of the two sectors, which also contains the services to be billed under ASV.[11]
Outpatient specialist care (ASV): ASV team.
aKBV-requirement catalog “Formularbedruckung” (form printing) dated 11.04.2014 (BSNR, establishment number). bNo referral required within core team. cContract medical providers will prefer settlement with the panel doctors’ association over settlement with the health insurance companies (which is also an option).
1.2.3 Notification procedure
In addition to meeting specific material and personnel requirements, participation in ASV also requires the implementation of a notification procedure. Under Section 2 para. 1 ASV Directive, service providers must report their meeting all requirements under the ASV Directive to the state committee in charge of the notification procedure. Generally, there are forms available for this, which can be ordered from the statutory health insurance associations or downloaded from their websites. The service provider will be authorized to participate in ASV 2 months after its notification has been received, unless the state committee informs the provider within such period of time that it has failed to meet the requirements for ASV participation (Section 116b para. 2 sentence 4 SGB V). It is further stated there that the period is “suspended” if the state committee demands additional information or statements. The question whether this represents a suspension or interruption in the period in legal terms has been answered in different ways in the literature. On the one hand, one opinion is that the 2-month period starts anew after receipt of the documentation requested.[12] On the other hand, referring to the intention of the legislator and waiving the conventional approval procedure for accelerating participation in ASV, it is believed that the 2-month period, once commenced, will merely be extended by the time span it takes to submit the documentation requested.[13] Given this lack of clarity with respect to the period, it is recommended that the service provider should obtain a certificate about its ASV eligibility prior to the provision of services, even though a formal approval is not really necessary.
1.3 Relevance of changes in law to the laboratory
In view of the changed legal framework, it is not only the hospitals (still) authorized under the former Section 116b SGB V that must decide whether and, if so, how and with what cooperation partners they can meet the requirements for future ASV participation. Laboratories, too, are faced with the decision as to whether they want to participate in ASV and how they can go about ensuring the applicable requirements. As Table 1 shows, for them, depending on the respective schedule of the ASV Directive, it is possible to participate as part of the core team or as a consulting physician. To regulate and prove cooperation to the state committee, cooperation agreements must be entered into that should reflect the content of services as well as the cooperation arrangement (regarding place of activity, billing, etc.). As for the place of performance, it should be noted that members of the core team must generally perform specialist medical services at the place of activity of the team management or at specific times at least 1 day a week at the place of activity of the team management. Only services tied to non-portable equipment as well as the preparation and examination of sample material taken from patients are excluded in this context. However, the place of performance for services to be performed directly on patients must be at an appropriate distance (as a rule, 30 min) from the place of activity of the team management – both for core team members and consulting physicians (Section 3 para. 2 sentence 4 et seq. ASV Directive).
1.4 Referral and settlement of services under ASV
Rules regarding referrals in the ASV context are specified, in particular, in Section 2 para. 4 and Section 8 ASV Directive. According to Section 2 para. 4 sentence 1 ASV Directive, there is no referral requirement between members of the core team. Consulting physicians perform their services, according to Section 2 para. 4 sentence 1 ASV Directive, in line with the respective treatment scope on referral (definition or indication order). All other details on the referral of laboratory services in connection with ASV are shown in Table 1. A distinction must be made, however, between the core team pursuant to Section 3 para. 2 sentence 2 ASV Directive and the interdisciplinary ASV team (consisting of team management, core team and consulting physicians).
The services under ASV will be reimbursed directly by the health insurance under Section 116b para. 6 sentence 1 SGB V. Panel doctors, however, may instruct the statutory health insurance association to handle the billing of these services against reimbursement of expenses. Until a separate billing system has been introduced under Section 116b para. 6 SGB V, billing will have to be done on the basis of the uniform rating scale[14] (EBM). Services and examinations allowed in the ASV context, but not implemented in EBM, can be identified by pseudo codes (uniform across the country) and submitted for billing until such time as they have been incorporated into EBM (chapter 50).[15] Because there are no corresponding EBM codes, service codes from the fee schedule for physicians (“GOÄ”) are applied in this exception. The services must be indicated in the ASV invoice and identified by the ASV team number. The GOÄ codes used as pseudo codes are entered in the IT system in the field “Non-Personnel Expenses Designation” (field ID 5011), and the prices in the field “Material Costs in Cents” (field ID 5012). Payment is made according to fees set for ASV under GOÄ (laboratory: factor 1.0). Excluded from the provision are ASV services that are also included in the oncology agreement.[16] Until they are included in EBM, they will be reimbursed according to the regional flat rates as per Schedule 2 of the oncology agreement.
Section 2 para. 1 sentence 3 ASV Directive provides that each service provider (no matter whether as team leader, core team member or consulting physician) remains ASV eligible and performs his/her ASV services independently within the context of the cooperation, which is why invoices to the health insurance or via instructions to the respective statutory health insurance association must also be settled separately by each ASV-eligible provider. There is no internal compensation and/or settlement between ASV cooperation partners.
One exception is the settlement of laboratory services that hospitals with an ASV authorization under Section 116b SGB V (old version) request from the lab. As before, and as illustrated in our review article, the lab must settle these services with the hospital. As soon as the provisions of hospitals under Section 116b SGB V (old version) have been repealed by the states, this settlement approach will be abandoned, and only the aforementioned ASV provisions will apply.
2 Complex of services codes
2.1 Differentiation of general conditions
Our article has given various examples of the billing and settlement of laboratory tests in connection with services subject to a complex of services codes and/or service complexes in general.[17] Apart from the general conditions already described there, we believe a further differentiation of the key service complexes in the area of statutory health insurance (GKV) is necessary, as is a compilation of the information that should be as definitive as possible.
Generally, doctors are reimbursed a flat fee for a services complex, with which all individual services contained in the complex service code are compensated. This means that these individual services cannot be billed and settled again outside the settlement via complex service codes. Consequently, the doctor who bills the complex service code must reimburse the laboratory for services that he/she does not perform or cannot perform and therefore orders these services from the lab. Such services complexes in connection with laboratory services are found in the context of so-called selective agreements, but also, indirectly, in EBM – often they are not apparent as such at first sight.
Since the laboratory, which only acts upon a referral, cannot know itself whether the lab services ordered concern such services complexes, making sure that the consulting physician orders the services correctly is key. Unfortunately, the general conditions for such compensation by complex service codes change at irregular intervals, particularly for selective agreements. What is more, this also affects primarily groups of physicians that order lab tests. Therefore, the following examples can only describe the basic system, but do not relieve the requesting doctor – as part of his/her request, which is always indication-based – of the regular need to ask whether and, if so, when lab services are already included in the services complex to be performed and billed by him/her.
2.2 Compensation by service codes for selective agreements
Probably the most prominent example of selective agreements may be the medical care centered on family physicians (“HzV”) under Section 73b SGB V. The family physician participating in such a selective agreement is paid for each patient registered under such agreement a flat fee, with which he/she must cover the various services. The services contained in the flat fee and thus paid are listed in the respective “range of codes” attached to the selective agreement. Among other things, these include laboratory services that the doctor can perform in his/her own practice (services under Section MI GOÄ) or procure from a private group laboratory (services under Section MII GOÄ) and/or from a specialist laboratory (services under Sections MIII and MIV GOÄ). If the doctor performs lab services himself/herself, or procures them from a private group laboratory, he/she will have to cover the costs incurred with the flat fee under the selective agreement.
Since the “ranges of codes” of selective agreements contain some services that are classified as basic laboratory services in EBM under chapter 32.2, while in GOÄ they are deemed specialist lab services under Section MIII, this oftentimes creates the problem that these services cannot be procured from a panel-doctor or a private group laboratory. This is so because a panel-doctor group lab requires direct billing to the health insurance (KV) and because a separate settlement at the expense of KV that exceeds the flat fee is not allowed under HzV agreements, while a private group lab can only perform services under Section MII GOÄ. As a result, these services can only be referred to a specialist lab as a specialist lab service under Section MIII GOÄ; that lab, then, bills the doctor.[18]
Overall, the number of existing selective agreements that also include laboratory services – even if one were to limit oneself only to HvZ agreements – is already quite extensive. In light of this, we have compiled an exemplary list of lab services in Table 2, which are part of the (German public health insurance company) AOK family physician contracts in force as of March 2015.
Complex numbers range GP-centered care (HzV).
KV District: | Baden Württemberg | Bavaria | Berlin and Brandenburg | Hesse | North Rhine | Westfalen-Lippe | ||||
---|---|---|---|---|---|---|---|---|---|---|
Health Insurance: | AOK | AOK | AOK | AOK | AOK | AOK | ||||
Contract: | AOK_Baden-Württembergc | AOK_Bavariad | AOK Northeast and IKK Brandenburg and Berlin | AOK_Hesse | AOK Rhineland/ Hamburg, Arbitration Agreements_North Rhine | AOK Northwest | ||||
Last update: | 2/13/2015 | 2/6/2015 | 2/18/2015 | 2/13/2015 | 2/13/2015 | 3/13/2015 | ||||
Entry into force: | 11/26/2014 | 10/1/2013 | 1/1/2014 | 1/1/2015 | 10/1/2013 | 10/1/2013 | ||||
EBM-GOP | GOP designation | Request => froma | Bill => to | GOÄ classificationb | X means ‘contained in range of codes’ | |||||
01708 | Lab tests, usually newborn screening, subject to authorization | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
01734 | Tests on blood in stool under Section D. III. of early cancer detection policy, incl. cost | Own practice or specialist lab | Sender | MI (no private group lab possible) | X | X | X | X | X | |
01826 | Cytological examination of one or more smears | Specialist laboratory | Sender | N (no private group lab possible) | X | X | X | X | X | |
01827 | Microscopic examination of the native smear | Specialist laboratory | Sender | N (no private group lab possible) | X | X | X | X | X | |
02401 | H2 breath test, incl. cost | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | X | |
31010 | Preoperative preparation for outpatient and GP procedures on neonates, infants, toddlers and children | Private group lab or specialist laboratory (concerns entire EBM 32) | Sender | MI to MIV possible | X | X | X | X | ||
31011 | Preoperative preparation for outpatient and GP procedures on adolescents and adults up to the age of 40 | Private group lab or specialist laboratory (concerns entire EBM 32) | Sender | MI to MIV possible | X | X | X | X | X | |
31012 | Preparation for surgery in ambulatory and GP procedures on patients after the age of 40, under the age of 60 | Private group lab or specialist laboratory (concerns entire EBM 32) | Sender | MI to MIV possible | X | X | X | X | X | |
31013 | Preparation for surgery in ambulatory and GP procedures on patients after the age of 60 | Private group lab or specialist laboratory (concerns entire EBM 32) | Sender | MI to MIV possible | X | X | X | X | X | |
32001 | Economic provision and/or instigation of services of Chapter 32 (on some points) | Is disregarded, unless services are referred outside the range of numbers | Is disregarded, unless services are referred outside the range of numbers | Is disregarded, unless services are referred outside the range of numbers | X | X | X | X | X | |
32025 | Glucose | Own practice | If performed at doctor’s practice | X | X | X | X | X | ||
32026 | TPZ (thromboplastin time) | Own practice | If performed at doctor’s practice | X | X | X | X | X | ||
32027 | D-dimer | Own practice | if performed at doctor’s practice | X | X | X | X | X | ||
32030 | Preliminary examination | Own practice or specialist lab | Sender | MI or MIII (no private group lab possible) | X | X | X | X | X | |
32031 | Urine microscopy | Own practice or specialist lab | Sender | MI or MIII (no private group lab possible) | X | X | X | X | X | |
32032 | PH value | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | X | |
32035 | Erythrocyte count | Own practice or standard blood count from private group lab | Sender | MI if done at doctor’s practice or MII | X | X | X | X | ||
32036 | Leukocyte count | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X | X | X | X | ||
32037 | Platelet count | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X | X | X | X | ||
32038 | Hemoglobin | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X | X | X | X | ||
32039 | Hematocrit | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X | X | X | X | ||
32040 | Blood in stool | Specialist laboratory | Sender | MI (no private group lab possible) | X | X | X | X | ||
32041 | Albumin in stool, qualitative | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32042 | BSR | Specialist laboratory | Sender | MI (no private group lab possible) | X | X | X | X | ||
32045 | Microscopic examination of body material | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32046 | Fetal hemoglobin in red blood cells | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32047 | Reticulocyte count | Private group lab | Sender | X | X | X | X | |||
32050 | Microscopic examination by Gram stain | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32051 | Differential blood count | Specialist laboratory | Sender | MI or MIII (no private group lab possible) | X | X | X | X | ||
32052 | Ingredients in 24-hour urine, quantitatively | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32055 | Determining the concentration of a drug | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32056 | Total protein | Private group lab | Sender | X | X | X | X | |||
32057 | Glucose | Private group lab | Sender | X | X only for 01732 | X | X | X | ||
32058 | Total bilirubin | Private group lab | Sender | X | X | X | X | |||
32059 | Bilirubin direct | Private group lab | Sender | X | X | X | X | |||
32060 | Total cholesterol | Private group lab | Sender | X | X only for 01732 | X | X | X | ||
32061 | HDL cholesterol | Private group lab | Sender | X | X only for 01732 | X | X | X | ||
32062 | LDL cholesterol | Private group lab | Sender | X | X only for 01732 | X | X | X | ||
32063 | Triglycerides | Private group lab | Sender | X | X only for 01732 | X | X | X | ||
32064 | Uric acid | Private group lab | Sender | X | X only for 01732 | X | X | X | ||
32065 | Urea | Private group lab | Sender | X | X | X | X | |||
32066 | Creatinine (Jaffe method) | Private group lab | Sender | X | X only for 01732 | X | X | X | ||
32067 | Creatinine, enzymatically | Private group lab | Sender | Private group lab, usually only the Jaffe method | X | X only for 01732 | X | X | X | |
32068 | Alkaline phosphatase | Private group lab | Sender | X | X | X | X | |||
32069 | GOT | Private group lab | Sender | X | X | X | X | |||
32070 | GPT | Private group lab | Sender | X | X | X | X | |||
32071 | Gamma-GT | Private group lab | Sender | X | X | X | X | |||
32072 | Alpha-amylase | Private group lab | Sender | X | X | X | X | |||
32073 | Lipase | Private group lab | Sender | X | X | X | X | |||
32074 | Creatine kinase (CK) | Private group lab | Sender | X | X | X | X | |||
32075 | LDH | Private group lab | Sender | X | X | X | X | |||
32076 | GLDH | Private group lab | Sender | X | X | X | X | |||
32077 | HBDH | Private group lab | Sender | X | X | X | X | |||
32078 | Cholinesterase | Private group lab | Sender | X | X | X | X | |||
32079 | Acid phosphatase | Private group lab | Sender | X | X | X | X | |||
32081 | Potassium | Private group lab | Sender | X | X | X | X | |||
32082 | Calcium | Private group lab | Sender | X | X | X | X | |||
32083 | Sodium | Private group lab | Sender | X | X | X | X | |||
32084 | Chloride | Private group lab | Sender | X | X | X | X | |||
32085 | Iron | Private group lab | Sender | X | X | X | X | |||
32086 | Phosphorus, inorganic | Private group lab | Sender | X | X | X | X | |||
32087 | Lithium | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32089 | Add. carrier-bound reagents | Own practice | If performed at doctor’s practice; MIII (no private group lab possible) | X | X | X | X | |||
32092 | CK-MB | Private group lab | Private group lab to sender | X | X | X | X | |||
32094 | HbA1, HbA1c | Private group lab | Private group lab to sender | X | X | X | X | |||
32097 | BNP and/or NT-Pro-BNP | Own practice or specialist lab | Sender | MIII (no private group lab possible) | X | |||||
32101 | TSH | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32103 | IgA | Private group lab | Sender | X | X | X | X | |||
32104 | IgG | Private group lab | Sender | X | X | X | X | |||
32105 | IgM | Private group lab | Sender | X | X | X | X | |||
32106 | Transferrin | Private group lab | Sender | X | X | X | X | |||
32107 | Serum electrophoresis | Private group lab | Sender | X | X | X | X | |||
32110 | Bleeding time (standardized) | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32111 | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | |||||
32112 | PTT | Private group lab | Sender | X | X | X | X | |||
32113 | Prothrombin time, plasma | Private group lab | Sender | X | X | X | X | |||
32114 | Prothrombin time, capillary blood | Private group lab | Sender | X | X | X | X | |||
32115 | Thrombin time | Private group lab | Sender | X | X | X | X | |||
32116 | Fibrinogen | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32117 | Fibrin monomers, fission products (qual.) | Specialist laboratory | Sender | MIII (no private group lab possible) | X | X | X | X | ||
32120 | Mechanized blood count, reticulocyte count | Private group lab | Sender | X | X | X | X | |||
32121 | Differential blood count | Private group lab | Sender | X | X | X | X | |||
32122 | Mechanized complete blood count | Private group lab | Sender | X | X | X | X | |||
32123 | Surcharge for subsequent microscopic differentiation | Specialist laboratory | Sender | MI or MIII (no private group lab possible) | X | X | X | X | ||
32124 | Determination of endogenous creatinine clearance | Private group lab | Sender | X | X | X | X | |||
32125 | Preoperative laboratory diagnostics: Erythrocytes, leukocytes, platelets, hemoglobin, hematocrit, potassium, blood glucose, creatinine, GGT | Private group lab | Sender | X | X | X | X | |||
32150 | Immunological detection of troponin I and/or troponin T on prefabricated reagent carrier with acute coronary syndrome (ACS), including, if necessary, equipment-based quantitative evaluation | Specialist laboratory | Sender | MIII (no private group lab possible) | X | |||||
32212 | Quantitative determination of the individual factors of the coagulation system, applies to the tariff positions 32210-32227, fibrin monomers, fibrin and/or fibrinogen degradation products, e.g. D-dimers | Specialist laboratory | Sender | MIII (no private group lab possible) | X | |||||
32232 | Quantitative chemical or physical analysis, applies to the tariff positions 32230-32236, 32240 and 32242-32246 and 32248, lactate | Specialist laboratory | Sender | MIII (no private group lab possible) | X | |||||
32880 | Preliminary testing for protein, glucose, erythrocytes, leukocytes and nitrite in the urine (no. 32030), laboratory flat fee for tests related to the fee schedule position 01732 | Own practice or specialist lab | Sender | MI or MIII (no private group lab possible) | X | X only for 01732 | X | |||
32881 | Lab flat fee for tests in connection with the provision of fee schedule position 01732 (health check) | Private group lab | Sender | X | X only for 01732 | X | ||||
32882 | Lab flat fee for tests in connection with the provision of fee schedule position 01732 (health check) | Private group lab | Sender | X | X only for 01732 | X |
aIt should be checked on a case-by-case basis which MII lab services can be provided by the respective private group laboratory. bThis is a description of the lab test classification for the GOÄ chapter. Some services of Chapter 32.2 EBM do not correspond to Chapter M II GOÄ and therefore cannot be procured from a private group laboratory. cPreliminary remark on the range of codes: BNP (32097), troponin qual. (32150), D-dimers (32212) and lactate (32232) marked as Section 73c-services: “Such services for insured patients registered with the AOK specialist doctor program cannot be settled by the family physician or any other doctor of the same BAG/MVZ with the KV. If the service is performed by the family physician or in his/her BAG/MVZ, it will generally be deemed paid through the flat fees under the present agreement. dPrinciple no. 5 of the preliminary remark on the HzV range of codes in effect from 01.10.2013, as amended by the 3rd interim agreement dated 02.10.2013. “All laboratory services are not part of this HzV agreement and must be settled via the KVB. Further laboratory services in connection with the services of health check (01732) and preoperative family physician care (2003) are part of the respective flat fee and are therefore deemed paid. These laboratory services are to be settled via a private card. In connection with 01732, the practice has to perform or purchase the following lab codes: 32057, 32060, 32061, 32062, 32063, 32064, 32066, 32067, 32880, 32881, 32882”.
The differences in the AOK ranges of codes show that each selective agreement must be checked for lab services included and their proper requisitioning in order to avoid subsequent recourses or reclaims in connection with the settlement of remuneration under collective agreements.
2.3 Compensation by service codes under EBM
There are also various service complexes in EBM. These include lab services for
Nephrology (dialysis);
Reproductive medicine (in-vitro fertilization, IVF);
Gastroenterology (colonoscopy);
Obstetrics (maternity guidelines);
Preoperative care;
Cardiac catheter examination.
The lab tests contained in these service complexes are summarized in Tables 3A–F. Based on the assignment in the respective EBM service legend, the following distinctions are made there:
Mandatory => these services must have been performed;
Optional => these services may be performed, but are then paid;
Billing exclusion => these services are not reimbursable in conjunction with the complex code or service complex;
Mentioned in the Federal Joint Committee directive.
Complex code range EBM, dialysis.
EBM chapter | III.a | III.b | ||||
EBM section | 4.5.4. | 13.3.6. | ||||
EBM-GOP, EBM-range | Preamble | Preamble | ||||
Description | Fee schedule positions of pediatric nephrology and dialysis | Fee schedule positions of nephrology and dialysis | ||||
Remark | No. 6: As long as the patient undergoes dialysis or LDL apheresis treatment, the fee schedule positions 32038, 32039, 32065, 32066 or 32067, 32068, 32081, 32082, 32083, 32086 and 32112 cannot be billed either by the doctor performing the dialysis or LDL apheresis or the doctor to whom these services are assigned. This additionally applies to the fee schedule position 04565, as it does to fee schedule position 32036. | No. 5: As long as the patient undergoes dialysis or LDL apheresis treatment, the fee schedule positions 32038, 32039, 32065, 32066 or 32067, 32068, 32081, 32082, 32083, 32086 and 32112 cannot be billed either by the doctor performing the dialysis or LDL apheresis or the doctor to whom these services are assigned. This additionally applies to the fee schedule position 13611, as it does to fee schedule position 32036. | ||||
EBM-GOP, EBM-range | GOP designation | Request => froma | Bill => to | GOÄ assignment | X means that this has been paid as part of the complex compensation, and cannot be settled together with the services complex | |
32036 | Leukocyte count | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X | X |
32038 | Hemoglobin | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X | X |
32039 | Hematocrit | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X | X |
32065 | Urea | Private group lab | Sender | X | X | |
32066 | Creatinine (Jaffe method) | Private group lab | Sender | X | X | |
32067 | Creatinine, enzymatically | Private group lab | Sender | Private group lab, usually the Jaffe method | X | X |
32068 | Alkaline phosphatase | Private group lab | Sender | X | X | |
32081 | Potassium | Private group lab | Sender | X | X | |
32082 | Calcium | Private group lab | Sender | X | X | |
32083 | Sodium | Private group lab | Sender | X | X | |
32086 | Phosphorus, inorganic | Private group lab | Sender | X | X | |
32112 | PTT | Private group lab | Sender | X | X |
aIt should be checked on a case-by-case basis which MII lab services can be provided by the respective private group laboratory.
Complex code range EBM, IVF.
EBM chapter | III.b | |||||||||
EBM section | 8.5 | |||||||||
EBM-GOP, EBM-range | 08540 | 08550 | 08551 | 08552 | 08560 | 08561 | ||||
Description | Collecting and examining sperm | In-vitro fertilization (IVF) followed by embryo transfer (ET) | Measures for in-vitro fertilization (IVF) in accordance with the fee schedule position 08550 | Measures for in-vitro fertilization (IVF) in accordance with the fee schedule positions 08550 and/or 08560 | IVF incl. ICSI followed by embryo transfer (ET) | IVF incl. ICSI to absence of cell division | ||||
Remark | Billing exclusion for treatment; according to no. 12.2 of the directives for artificial insemination, treatment and capacitation, possibly incl. medical laboratory testing | Billing exclusion for treatment cycle; according to no. 10.3 of the directives for artificial insemination, incl. all services necessary for the implementation of the treatment cycle except for the measures referred to in 12.1, 12.2. and 12.6 | Billing exclusion for treatment cycle; according to no. 10.3 of the directives for artificial insemination, incl. all services necessary for the implementation of the treatment cycle except for the measures referred to in 12.1, 12.2. and 12.6 | Billing exclusion for treatment cycle; according to no. 10.3 of the directives for artificial insemination, incl. all services necessary for the implementation of the treatment cycle except for the measures referred to in 12.1, 12.2. and 12.6 | Billing exclusion for treatment cycle; according to no. 10.5 of the directives for artificial insemination, incl. all services necessary for the implementation of the treatment cycle except for the measures referred to in 12.1, 12.2. and 12.6 | Billing exclusion for treatment cycle; according to no. 10.5 of the directives for artificial insemination, incl. all services necessary for the implementation of the treatment cycle except for the measures referred to in 12.1, 12.2. and 12.6 | ||||
EBM-GOP, EBM-range | GOP designation | Request => froma | Bill => to | GOÄ assignment | X means that this has been paid as part of the complex compensation, and cannot be settled together with the services complex | |||||
32190 | Spermiogram | Specialist laboratory | Sender | MIII, no private group lab possible | X, billing exclusion | |||||
32354 | Luteinizing hormone (LH) | Specialist laboratory | Sender | MIII, no private group lab possible | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | |
32356 | Estradiol | Specialist laboratory | Sender | MIII, no private group lab possible | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | |
32357 | Progesterone | Specialist laboratory | Sender | MIII, no private group lab possible | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | X, mentioned in the Federal Joint Committee directive | |
Chap. 32 EBM | Laboratory Medicine, Molecular Genetics and Molecular Pathology | Private group lab or specialist laboratory | Sender | X, billing exclusion | X, billing exclusion | X, billing exclusion | X, billing exclusion | X, billing exclusion |
aIt should be checked on a case-by-case basis which MII lab services can be provided by the respective private group laboratory.
Complex code range EBM, colonoscopy.
EBM chapter | II | III.a | III.b | ||||
EBM section | 1.7.2. | 4.5.1. | 13.3.3. | ||||
EBM-GOP, EBM-range | 01741 | 04514 | 13421 | ||||
Description | Colonoscopy complex according to early cancer detection guidelines | Additional flat fee colonoscopy in the infant, toddler, child or young person | Additional flat fee colonoscopy | ||||
Remark | Optional service content and billing exclusion: Coagulation tests and standard blood count | Optional service content: Coagulation tests and standard blood count | Optional service content: Coagulation tests and standard blood count | ||||
EBM-GOP, EBM-range | GOP designation | Request => froma | Bill => to | GOÄ assignment | X means that this has been paid as part of the complex compensation, and cannot be settled together with the services complex | ||
32110 | Bleeding time (standardized) | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional, billing exclusion | X, optional | X, optional |
32111 | Recalcification time | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional, billing exclusion | X, optional | X, optional |
32112 | PTT | Private group lab | Sender | X, optional, billing exclusion | X, optional | X, optional | |
32113 | Prothrombin time, plasma | Private group lab | Sender | X, optional, billing exclusion | X, optional | X, optional | |
32114 | Prothrombin time, capillary blood | Private group lab | Sender | X, optional, billing exclusion | X, optional | X, optional | |
32115 | Thrombin time | Private group lab | Sender | X, optional, billing exclusion | X, optional | X, optional | |
32116 | Fibrinogen | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional, billing exclusion | X, optional | X, optional |
32117 | Fibrin monomers, fission products (qual.) | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional, billing exclusion | X, optional | X, optional |
32120 | Mechanized blood count, reticulocyte count | Private group lab | Sender | X, optional, billing exclusion | X, optional | X, optional |
aIt should be checked on a case-by-case basis which MII lab services can be provided by the respective private group laboratory.
Complex code range EBM, gynecology.
EBM chapter | II | |||||
EBM section | 1.7.4. | 1.7.7. | ||||
EBM-GOP, EBM-range | 01770 | 01900 | ||||
Description | Care of pregnant women according to maternity guidelines | Consulting for planned abortion | ||||
Remark | According to Section 2. b) and 4. Maternity Guidelines in conjunction with Cologne comments for EBM | Optional service content: Immunological pregnancy tests | ||||
EBM-GOP, EBM-range | GOP designation | Request => froma | Bill => to | GOÄ assignment | X means that this has been paid as part of the complex compensation, and cannot be settled together with the services complex | |
32035 | Erythrocyte count | Own practice or specialist lab | Sender | MI or MIII, no private group lab possible | X, mentioned in the Federal Joint Committee directive | |
32038 | Hemoglobin | Own practice or specialist lab | Sender | MI or MIII, no private group lab possible | X, mentioned in the Federal Joint Committee directive | |
32030 | Preliminary examination (protein, sugar in the urine) | Own practice or specialist lab | Sender | MI or MIII, no private group lab possible | X, mentioned in the Federal Joint Committee directive | |
32031 | Microscopic examination of the urine for morphological components | Own practice or specialist lab | Sender | MI or MIII, no private group lab possible | X, mentioned in the Federal Joint Committee directive | |
32120 | Mechanized blood count, reticulocyte count | Private group lab | Sender | X, mentioned in the Federal Joint Committee directive | ||
32132 | Immunological pregnancy tests | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional | |
32352 | Chorionic gonadotropin (HCG and/or ß-HCG) | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional |
aIt should be checked on a case-by-case basis which MII lab services can be provided by the respective private group laboratory.
Complex code range EBM, preoperative care.
EBM chapter | IV | ||||||||
EBM section | 31.1.2. | 32.2.5. | |||||||
EBM-GOP, EBM-range | 31010 | 31011 | 31012 | 31013 | 32125 | ||||
Description | Preparation for surgery in neonates, infants, toddlers and children up to age 12 | Preoperative preparation for procedures on adolescents and adults up to the age of 40 | Preparation for surgery for procedures on patients after the age of 40 | Preparation for surgery for procedures on patients after the age of 60 | Pre-operative laboratory diagnosis before procedures under general anesthesia or neuraxial regional anesthesia | ||||
Remark | Optional service content: Laboratory tests (Nos. 32101, 32125 and/or 32110–32116) Billing exclusion on day of treatment: Chap. 32 | Optional service content: Laboratory tests (Nos. 32101, 32125 and/or 32110–32116) Billing exclusion on day of treatment: Chap. 32 | Optional service content: Laboratory tests (Nos. 32101, 32125 and/or 32110–32116) Billing exclusion on day of treatment: Chap. 32 | Mandatory service content: 32125 and/or 32110-32116 Optional service content: 32101, additional laboratory diagnostics acc. to 32.2) Billing exclusion on day of treatment: Chap. 32 | Billing exclusion in the same session | ||||
EBM-GOP, EBM-range | GOP designation | Request => froma | Bill => to | GOÄ assignment | X means that this has been paid as part of the complex compensation, and cannot be settled together with the services complex | ||||
32035 | Erythrocyte count | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X, billing exclusion | ||||
32036 | Leukocyte count | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X, billing exclusion | ||||
32037 | Platelet count | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X, billing exclusion | ||||
32038 | Hemoglobin | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X, billing exclusion | ||||
32039 | Hematocrit | Own practice or standard blood count from private group lab | Sender | If performed at doctor’s practice, otherwise private group lab | X, billing exclusion | ||||
32047 | Reticulocyte count | Private group lab | Sender | X, billing exclusion | |||||
32057 | Glucose | Private group lab | Sender | X, billing exclusion | |||||
32066 | Creatinine (Jaffe method) | Private group lab | Sender | X, billing exclusion | |||||
32067 | Creatinine, enzymatically | Private group lab | Sender | Private group lab, usually the Jaffe method | X, billing exclusion | ||||
32071 | Gamma-GT | Private group lab | Sender | X, billing exclusion | |||||
32081 | Potassium | Private group lab | Sender | X, billing exclusion | |||||
32101 | TSH | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional | X, optional | X, optional | X, optional | |
32110 | Bleeding time (standardized) | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional | X, optional | X, optional | X, mandatory | |
32111 | Recalcification time | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional | X, optional | X, optional | X, mandatory | |
32112 | PTT | Private group lab | Sender | X, optional | X, optional | X, optional | X, mandatory | ||
32113 | Prothrombin time, plasma | Private group lab | Sender | X, optional | X, optional | X, optional | X, mandatory | ||
32114 | Prothrombin time, capillary blood | Private group lab | Sender | X, optional | X, optional | X, optional | X, mandatory | ||
32115 | Thrombin time | Private group lab | Sender | X, optional | X, optional | X, optional | X, mandatory | ||
32116 | Fibrinogen | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional | X, optional | X, optional | X, mandatory | |
32120 | Mechanized blood count, reticulocyte count | Private group lab | Sender | X, billing exclusion | |||||
32122 | Mechanized complete blood count | Private group lab | Sender | X, billing exclusion | |||||
32125 | Preoperative laboratory diagnostics | Private group lab | Sender | X, optional | X, optional | X, optional | X, mandatory | ||
Chap. 32 EBM | Laboratory medicine, molecular genetics and molecular pathology | Private group lab or specialist laboratory | Sender | X, billing exclusion | X, billing exclusion | X, billing exclusion | X, billing exclusion | ||
Chap. 32.2 EBM | General laboratory tests | Private group lab or specialist laboratory | Sender | X, optional |
aIt should be checked on a case-by-case basis which MII lab services can be provided by the respective private group laboratory.
Complex code range EBM, cardiac catheter.
EBM chapter | IV | ||||
EBM section | 34.2.9. | ||||
EBM-GOP, EBM-range | 34291 | ||||
Description | Cardiac catheter examination with coronary angiography | ||||
Remark | Optional service content: Coagulation test(s) (e.g. activated clotting time); Billing exclusion in the same session: Chap. 32 | ||||
EBM-GOP, EBM-range | GOP designation | Request => froma | Bill => to | GOÄ assignment | X means that this has been paid as part of the complex compensation, and cannot be settled together with the services complex |
32110 | Bleeding time (standardized) | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional |
32111 | Recalcification time | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional |
32112 | PTT | Private group lab | Sender | X, optional | |
32113 | Prothrombin time, plasma | Private group lab | Sender | X, optional | |
32114 | Prothrombin time, capillary blood | Private group lab | Sender | X, optional | |
32115 | Thrombin time | Private group lab | Sender | X, optional | |
32116 | Fibrinogen | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional |
32117 | Fibrin monomers, fission products (qual.) | Specialist laboratory | Sender | MIII, no private group lab possible | X, optional |
Chap. 32 EBM | Laboratory Medicine, Molecular Genetics and Molecular Pathology | Private group lab or specialist laboratory | Sender | X, billing exclusion |
aIt should be checked on a case-by-case basis which MII lab services can be provided by the respective private group laboratory.
Here, too, and for any further EBM service complexes, attention must be paid to the correct requisitioning by the treating, ordering physician as well as the correct billing to the requester by the commissioned lab performing the services.
3 Occupational medicine
At this point, our previous explanations[19] refer only to the constellation where the occupational physician or company doctor works as part of an employment relationship with the company or performs his/her services independently on the basis of a fee agreement and settles with the company outside the GOÄ (for example, based on flat fees or budgets). It is only in these cases that a laboratory can invoice specialist lab services under Sections MIII and MIV of GOÄ to the requesting occupational physician or company doctor.
But where the occupational physician or company doctor settles his/her own services with the company on the basis of GOÄ, he/she cannot, given the Federal Court decision dated 25.01.2012 (Ref.: 1 StR 45/11), procure any services from the lab under Sections MIII and MIV of GOÄ and bill these as his/her own services. In this case, he/she may only request the lab services, and the lab must then bill the company (that is, the payer) for the services. However, the settlement conditions between the lab and the company are freely negotiable.
It is therefore crucial against this background that the occupational physician or company doctor inform the laboratory whether he/she settles accounts as part of GOÄ or outside the GOÄ framework. This may be done by way of an agreement between the requester and the lab, or may be noted on the lab order form in individual cases. If the laboratory does not know the billing method of the requester, the lab should settle directly with the company to avoid legal risks.
4 Billing hospital/emergency room
This part serves to deepen one’s understanding of the individual billing constellations in connection with hospital emergency rooms, as well as to point out billing-relevant trends. Following up on our review article,[20] we have generally identified the following billing options for laboratory services that a hospital emergency room orders for patients with statutory health insurance.
4.1 Laboratory as an operational unit of the hospital
If the laboratory is an integral part of the hospital’s operations, the lab services must be settled by the hospital directly with the competent panel doctors’ association in a manner previously agreed between the hospital and the association.
4.2 Laboratory as an outsourced external operation without separate license
If the laboratory is an external operation outsourced from the hospital that does not have its own license for panel-doctor care, the hospital will be billed by the laboratory performing the services for lab services requested via a hospital-specific order form. The hospital then usually settles the services with the panel doctors’ association in accordance with a method previously agreed between the hospital and the association.
4.3 Laboratory as an outsourced external operation with separate license
If the laboratory is an external operation outsourced from the hospital that has its own license for panel-doctor care (e.g. MVZ with panel-doctor license), the laboratory will settle lab services directly with the competent panel doctors’ association following a referral by the emergency room on the basis of the Model 10 form.
Since basic lab services are often performed by the hospital’s own, on-site laboratory, while specialist lab services are procured from an external specialist laboratory, such cases create mixed constellations that fall in between the billing options described.
4.4 Scope of billable emergency services
Regarding the question of the billable scope of emergency services, the Federal Social Court decided on 12.12.2012 (Ref.: B 6 KA 5/12 R) that lab tests on blood alcohol content and on C-reactive protein are not generally part of emergency services, because they usually are not medically indicated or useful in primary care.
In light of this, and from the perspective of emergency rooms and/or hospitals, it might be useful to clarify with the competent panel doctors’ association the services that can be settled as part of emergency care, and to what extent.
Legal sources and references
Doctors’ fee schedule, as published on 09.02.1996, as amended by the Act dated 04.12.2001.
Uniform rating scale, as amended with effect from 01.04.2015.
Social Code Book V, dated 20.12.1988, as amended by the Act of 15.04.2015.
Federal master agreement with doctors, as amended on 01.01.2015.
Directive by the Federal Joint Committee on specialist outpatient medical treatment under Section 116b SGB V, as published on 21.03.2013, as amended on 20.02.2014.
“Tuberculosis and atypical mycobacteriosis”, decision of 19.12.2013, entered into force on 24.04.2014.
“Gastrointestinal tumors and tumors of the abdominal cavity”, decision of 02.20.2014, entered into force on 26.07.2014.
“Gynecological tumors”, decision of 22.01.2015, not yet in force.
“Marfan’s syndrome”, decision of 22.01.2015, not yet in force.
Kasseler Kommentar zum Sozialversicherungsrecht, last update: 01.12.2014, Verlag C.H. Beck München.
Schedule 5 of the agreement under Section 116b para. 6 sentence 12 SGB V regarding the form and content of the billing procedure as well as the required forms for outpatient specialist care (ASV-AV), which entered into force on 01.10.2014.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Article note:
Original German online version at: http://www.degruyter.com/view/j/labm.2015.39.issue-4/labmed-2015-0056/labmed-2015-0056.xml?format=INT. The German article was translated by Compuscript Ltd. and authorized by the authors.
©2016 by De Gruyter
Articles in the same Issue
- The influence of the trace element zinc on the immune system
- Lipoprotein(a): when to measure, how to treat?
- Diagnostics and importance of hepatitis E virus infections
- Hemoglobin variants – pathomechanism, symptoms and diagnosis
- In-vitro allergy diagnostics
- Diagnostics of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
- A systematic approach to billing laboratory services – the legal framework: Supplement and update to the article in J Lab Med 2014; 38(4):179–205
- Diagnostic relevance of CSF interleukin-6
- Stepwise diagnostic procedure for the analysis of pathological changes of leukocytes
- Simple estimation of reference intervals from routine laboratory data
- Rational diagnostic work-up of anemia
- Quality assurance in the analysis of growth hormone and insulin-like growth factor I in disorders of the somatotropic axis
- Stepwise diagnostics of hemoglobinopathies
Articles in the same Issue
- The influence of the trace element zinc on the immune system
- Lipoprotein(a): when to measure, how to treat?
- Diagnostics and importance of hepatitis E virus infections
- Hemoglobin variants – pathomechanism, symptoms and diagnosis
- In-vitro allergy diagnostics
- Diagnostics of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
- A systematic approach to billing laboratory services – the legal framework: Supplement and update to the article in J Lab Med 2014; 38(4):179–205
- Diagnostic relevance of CSF interleukin-6
- Stepwise diagnostic procedure for the analysis of pathological changes of leukocytes
- Simple estimation of reference intervals from routine laboratory data
- Rational diagnostic work-up of anemia
- Quality assurance in the analysis of growth hormone and insulin-like growth factor I in disorders of the somatotropic axis
- Stepwise diagnostics of hemoglobinopathies